Database: EUROCARE (European Union): Difference between revisions

Revision as of 13:58, 31 May 2024

Type of Database: registry

Primary purpose: To monitor cancer survival, measure cancer prevalence, and study patterns of care for cancer patients across Europe. Click here to learn more.

Sponsor, manager or home institution: the Istituto Nazionale dei Tumori (INT Milan) and the Istituto Superiore di Sanità (Rome). Patient-level data is owned by each individual cancer registry. Click here to learn more.

Type of information: Cancer Site, Population, age Class, ICSS - International cancer survival Standards, Time from Diagnosis, sex, and Output Indicators including: Alive at Start, Observed Survival, Cumulative (OSC), Relative Survival, Cumulative (RSC), Relative SE's, Cumulative (RSEC), Dead, Expected Survival, Interval (ESI), Observed SE's, Interval (OSEI), RSC: Lower bound (95% CI), Lost to Follow Up, Expected Survival, Cumulative (ESC), Observed SE's, Cumulative (OSEC), RSC: Upper bound (95% CI), Observed Survival, Interval (OSI), Relative Survival, Interval (RSI), Relative SE's, Interval (RSEI). Click here to learn more.

Source of Information: 99 cancer registries from 29 countries participating in the study provided their patient-level data as of the 5th Edition of EUROCARE. Click here to learn more.

Data level: national level.

Number of Records: 9,000,000. Click here to learn more.

Date range: 2000 to 2007.

Cancer Areas of Interest: C00-C97: All cancer types.

Data access: publicly available. Click here to access. Databases from previous editions of the EUROCARE study are also available. Click here to access.

Contact information: Click here to access.

@@ Line 8: / Line 8: @@
 '''Sponsor, manager or home institution:''' [[dataOwner::the Istituto Nazionale dei Tumori (INT Milan)]] and the [[dataOwner::Istituto Superiore di Sanità (Rome)]]. Patient-level data is owned by each individual cancer registry. [https://eu5results.iss.it/docs/Documentation_on_data_and_%20methods.pdf Click here to learn more].
-'''Type of information:''' Cancer Site, Population, Age Class, ICSS - International Cancer Survival Standards, Time from Diagnosis, Sex, and Output Indicators including: Alive at Start, Observed Survival, Cumulative (OSC), Relative Survival, Cumulative (RSC), Relative SE's, Cumulative (RSEC), Dead, Expected Survival, Interval (ESI), Observed SE's, Interval (OSEI), RSC: Lower bound (95% CI), Lost to Follow Up, Expected Survival, Cumulative (ESC), Observed SE's, Cumulative (OSEC), RSC: Upper bound (95% CI), Observed Survival, Interval (OSI), Relative Survival, Interval (RSI), Relative SE's, Interval (RSEI).
+'''Type of information:''' [[availableVariable::diagnosis|Cancer Site]], Population, [[availableVariable::age]] Class, ICSS - International [[availableVariable::cancer survival]] Standards, Time from Diagnosis, [[availableVariable::sex]], and Output Indicators including: Alive at Start, Observed Survival, Cumulative (OSC), Relative Survival, Cumulative (RSC), Relative SE's, Cumulative (RSEC), [[availableVariable::number of deaths|Dead]], Expected Survival, Interval (ESI), Observed SE's, Interval (OSEI), RSC: Lower bound (95% CI), Lost to Follow Up, Expected Survival, Cumulative (ESC), Observed SE's, Cumulative (OSEC), RSC: Upper bound (95% CI), Observed Survival, Interval (OSI), Relative Survival, Interval (RSI), Relative SE's, Interval (RSEI). [https://eu5results.iss.it/forms/SA0007.aspx Click here to learn more].
 '''Source of Information:''' 99 cancer registries from 29 countries participating in the study provided their patient-level data as of the 5th Edition of EUROCARE. [https://eu5results.iss.it/docs/Documentation_on_data_and_%20methods.pdf Click here to learn more].